BR9610905A - Derivados de sulfamato processo de fabricação de derivados de sulfamato e composições farmacêuticas - Google Patents

Derivados de sulfamato processo de fabricação de derivados de sulfamato e composições farmacêuticas

Info

Publication number: BR9610905A
Authority: BR; Brazil
Prior art keywords: sulfamate derivatives; manufacturing process; pharmaceutical compositions; derivatives; sulfamate
Prior art date: 1995-10-19

Application number

BR9610905A

Other languages

English (en)

Inventor

Sigfrid Schwarz

Walter Elger

Gudrun Reddersen

Birgitt Schneider

Ina Thieme

Margit Richter

Original Assignee

Jenapharm Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-10-19

Filing date

1996-09-19

Publication date

1999-07-13

1996-09-19 Application filed by Jenapharm Gmbh filed Critical Jenapharm Gmbh

1999-07-13 Publication of BR9610905A publication Critical patent/BR9610905A/pt

Links

-1 Sulfamate derivatives sulfamate derivatives Chemical class 0.000 title 1
238000004519 manufacturing process Methods 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1
150000001875 compounds Chemical class 0.000 abstract 3
230000001076 estrogenic effect Effects 0.000 abstract 1
IIACRCGMVDHOTQ-UHFFFAOYSA-N sulfamic acid Chemical class NS(O)(=O)=O IIACRCGMVDHOTQ-UHFFFAOYSA-N 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0072—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the A ring of the steroid being aromatic
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/32—Antioestrogens

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Diabetes (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Endocrinology (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Steroid Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Peptides Or Proteins (AREA)

BR9610905A 1995-10-19 1996-09-19 Derivados de sulfamato processo de fabricação de derivados de sulfamato e composições farmacêuticas BR9610905A (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE19540233A DE19540233B4 (de)	1995-10-19	1995-10-19	Sulfamat-Derivate von 1,3,5(10)-Estratrien-Derivaten, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
PCT/DE1996/001823 WO1997014712A2 (de)	1995-10-19	1996-09-19	Sulfamat-derivate von 1,3,5(10)-estratrien-derivaten, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen

Publications (1)

Publication Number	Publication Date
BR9610905A true BR9610905A (pt)	1999-07-13

Family

ID=7776061

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BR9610905A BR9610905A (pt)	1995-10-19	1996-09-19	Derivados de sulfamato processo de fabricação de derivados de sulfamato e composições farmacêuticas

Country Status (13)

Country	Link
EP (1)	EP0862577B1 (pt)
JP (2)	JPH11505268A (pt)
KR (1)	KR100306044B1 (pt)
CN (1)	CN1125077C (pt)
AT (1)	ATE178903T1 (pt)
AU (1)	AU1436097A (pt)
BR (1)	BR9610905A (pt)
DE (2)	DE19540233B4 (pt)
DK (1)	DK0862577T3 (pt)
ES (1)	ES2131972T3 (pt)
GR (1)	GR3030733T3 (pt)
RU (1)	RU2159774C2 (pt)
WO (1)	WO1997014712A2 (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9118478D0 (en) *	1991-08-29	1991-10-16	Imperial College	Steroid sulphatase inhibitors
DE19712488A1 (de) *	1997-03-25	1998-10-01	Knoell Hans Forschung Ev	Steroidsulfamate, Verfahren zu ihrer Herstellung und Anwendung derselben
US6288050B1 (en) *	1997-07-18	2001-09-11	Duquesne University Of The Holy Ghost	Steroid sulfatase inhibitors and methods for making and using the same
ATE401896T1 (de)	1998-06-10	2008-08-15	Sterix Ltd	Pharmazeutische zusammensetzungen mit tumor nekrose faktor und 2-methoxyestron-3-o-sulphamat als estrone sulphatasehemmern
US6248780B1 (en)	1998-10-01	2001-06-19	Duquesne University Of The Holy Ghost	Compounds for the treatment of estrogen-dependent illnesses and methods for making and using the same
DE19943708B4 (de) *	1999-09-08	2007-12-20	Bayer Schering Pharma Ag	Neue C13-substituierte Estra-1,3,5(10)-trien-3-yl-sulfamate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
US6583130B1 (en)	1999-09-13	2003-06-24	Schering Ag	C13-substituted estra-1,3,5,(10)-trien-3-yl sulfamates, methods of preparing same, and pharmaceutical compositions containing these compounds
EP1769799A3 (en) *	2000-01-14	2010-01-13	Sterix Limited	Pharmaceutical compositions containing steroidal structures and uses thereof
DE10027887A1 (de) *	2000-05-31	2001-12-13	Jenapharm Gmbh	Verbindungen mit einer Sulfonamidgruppe und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen
US8026229B2 (en)	2001-08-13	2011-09-27	Sterix Limited	Antitumor-active 2-alkoxyestradiol sulfamates
DE10139494A1 (de) *	2001-08-13	2003-03-06	Jenapharm Gmbh	Antitumor wirksame 2-Alkoxyestradiolsulfamate
DE10307105A1 (de) *	2003-02-19	2004-09-09	Schering Ag	Antitumor wirksame 2-substituierte 18a-Homoestra-1,3,5(10)-trien-3-yl sulfamate
DE10307104A1 (de) *	2003-02-19	2004-09-23	Schering Ag	Antitumor wirksame 2-substituierte Estra-1,3,5(10)-trien-3-yl sulfamate
DE10307103A1 (de)	2003-02-19	2004-09-09	Schering Ag	Antitumor wirksame 2-substituierte D-Homostra-1,3,5(10)-trien-3-yl sulfamate
US7534780B2 (en)	2004-05-21	2009-05-19	Bayer Schering Pharma Aktiengesellschaft	Estradiol prodrugs
US20080292765A1 (en) *	2007-05-22	2008-11-27	The Coca-Cola Company	Sweetness Enhancers, Sweetness Enhanced Sweetener Compositions, Methods for Their Formulation, and Uses
GB201302368D0 (en) *	2013-02-11	2013-03-27	Univ Bath	Compound
RU2562242C1 (ru) *	2014-07-10	2015-09-10	Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Санкт-Петербургский государственный университет" (СПбГУ)	РАЦЕМИЧЕСКИЙ 2,17β-ДИСУЛЬФАМОИЛОКСИ-3-МЕТОКСИ-8α-ЭСТРА-1,3,5(10)-ТРИЕН В КАЧЕСТВЕ ИНГИБИТОРА ПРОЛИФЕРАЦИИ ОПУХОЛЕВЫХ КЛЕТОК MCF-7

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2133484A2 (en) *	1969-04-29	1972-12-01	Jenapharm Veb	3-17 and 21-sulphonyloxy-steroids - with androgenic anabolic progestogenic and oestrogen activity of long duration
IL94183A (en) *	1989-05-05	2003-09-17	Baylor College Medicine	cDNA SEQUENCE CODING FOR HUMAN LACTOFERRIN PROTEIN OR PORTION THEREOF AND LACTOFERRIN PROTEIN PRODUCED FROM SAID SEQUENCE
DE69032616T2 (de) *	1989-06-16	1999-03-11	Genencor International, Inc., Rochester, N.Y.	Dna-sequenzen, vektoren und fusionspolypeptide zur erhöhung der sekretion gewünschter polypeptide von filamentösen fungi
JP2818056B2 (ja) *	1990-09-07	1998-10-30	森永乳業株式会社	抗菌性ペプチドおよび抗菌剤
ZA932568B (en) *	1992-04-24	1993-11-12	Baylor College Midecine A Non	Production of recombinant human lactoferrin

1995
- 1995-10-19 DE DE19540233A patent/DE19540233B4/de not_active Expired - Fee Related
1996
- 1996-09-19 WO PCT/DE1996/001823 patent/WO1997014712A2/de not_active Ceased
- 1996-09-19 AT AT96945140T patent/ATE178903T1/de not_active IP Right Cessation
- 1996-09-19 KR KR1019980702625A patent/KR100306044B1/ko not_active Expired - Fee Related
- 1996-09-19 RU RU98109708/04A patent/RU2159774C2/ru not_active IP Right Cessation
- 1996-09-19 CN CN96197673A patent/CN1125077C/zh not_active Expired - Fee Related
- 1996-09-19 ES ES96945140T patent/ES2131972T3/es not_active Expired - Lifetime
- 1996-09-19 DE DE59601683T patent/DE59601683D1/de not_active Expired - Lifetime
- 1996-09-19 JP JP9515400A patent/JPH11505268A/ja not_active Ceased
- 1996-09-19 JP JP09515400A patent/JP3040175B2/ja not_active Expired - Fee Related
- 1996-09-19 AU AU14360/97A patent/AU1436097A/en not_active Abandoned
- 1996-09-19 EP EP96945140A patent/EP0862577B1/de not_active Expired - Lifetime
- 1996-09-19 DK DK96945140T patent/DK0862577T3/da active
- 1996-09-19 BR BR9610905A patent/BR9610905A/pt not_active IP Right Cessation
1999
- 1999-07-09 GR GR990401812T patent/GR3030733T3/el unknown

Also Published As

Publication number	Publication date
DK0862577T3 (da)	1999-10-25
EP0862577B1 (de)	1999-04-14
AU1436097A (en)	1997-05-07
CN1200126A (zh)	1998-11-25
ES2131972T3 (es)	1999-08-01
ATE178903T1 (de)	1999-04-15
DE19540233A1 (de)	1997-04-24
DE59601683D1 (de)	1999-05-20
DE19540233B4 (de)	2005-08-25
GR3030733T3 (en)	1999-11-30
EP0862577A2 (de)	1998-09-09
JPH11505268A (ja)	1999-05-18
KR19990064144A (ko)	1999-07-26
CN1125077C (zh)	2003-10-22
WO1997014712A2 (de)	1997-04-24
JP3040175B2 (ja)	2000-05-08
WO1997014712A3 (de)	1997-06-05
RU2159774C2 (ru)	2000-11-27
KR100306044B1 (ko)	2001-12-05

Similar Documents

Publication	Publication Date	Title
BR9610905A (pt)	1999-07-13	Derivados de sulfamato processo de fabricação de derivados de sulfamato e composições farmacêuticas
PT96857A (pt)	1991-10-31	Processo para a preparacao de oxetanonas
ATE36149T1 (de)	1988-08-15	Antikonvulsive sulfamatderivate.
IT1222394B (it)	1990-09-05	Processo per la preparazione di 2,2,6,6 tetrametil 4 piperidilammine
EA199800768A1 (ru)	1999-02-25	Новые производные эритромицина, способ их получения и их применение в качестве медикаментов
BR9813391A (pt)	2000-10-10	Composição de epo, preparado farmacêutico e processos para produzir uma composição de epo e para aumentar a atividade especìfica de uma composição de epo
PT98375A (pt)	1992-05-29	Processo de preparacao de compostos de piperidina e de composicoes farmaceuticas
EP0021231A3 (en)	1981-04-01	Process for the preparation of 5'-deoxy-5-fluoro uridine and intermediates in this process as well as their application
IT8920917A0 (it)	1989-06-20	Processo per la preparazione di peraloeteri da peraloolefine e nuovi peraloeteri ottenuti.
ES2080140T3 (es)	1996-02-01	Derivados de eritromicina.
BG104232A (bg)	2000-10-31	Заместени 1,2,3,4,5,6-хексахидро-2,6-метано-3-бензазоцин- 10-оли, метод за тяхното получаване и приложението им като лекарствени средства
DE69926223D1 (de)	2005-08-25	Verfahren zur herstellung von zwischenprodukten
SE9504618D0 (sv)	1995-12-22	New Compounds
ATE147749T1 (de)	1997-02-15	Verfahren zur herstellung von azt(3'-azido-3'- desoxythymidin) und diebezüglichen verbindungen
NZ510116A (en)	2002-10-25	Tricyclic delta-3-piperidines as pharmaceuticals
IT1190116B (it)	1988-02-10	Processo per la sintesi di mono o di idrossifluoroalcani
BR9610175A (pt)	1998-08-11	Composto processo de preparação do composto composição farmacêutica e utilização do composto
HUT43614A (en)	1987-11-30	Process for producing isohexide-nucleosides and pharmaceutical compositions containing them
PT93071A (pt)	1990-08-31	Processo para a preparacao de novas 4`-epi-4`-amino-antraciclinas e de composicoes farmaceuticas que as contem
BR0012481A (pt)	2002-04-02	Processo para desacilação de lipodepsipeptìdeos
BR9714007A (pt)	2000-05-09	Novos derivados da eritromicina seu processo de preparação e sua aplicação como medicamentos
ATE131155T1 (de)	1995-12-15	Verfahren zur herstellung von zwischenprodukten und zur synthese von n-(2-hydroxyethyl)-2- hydroxymethyl-3,4,5-trihydroxypiperidine.
GR80173B (en)	1985-01-02	Spiro (benzofuran-azalkanes), method for their preparation and their use as medicaments
SE8702527D0 (sv)	1987-06-17	Metylenderivat av androst-4-en-3,17-dioner och forfarande for deras framstellning
PT1056769E (pt)	2002-11-29	15-metil-ciclopropanoesteroides e processo para a sua preparacao

Legal Events

Date	Code	Title	Description
2005-08-23	B25C	Requirement related to requested transfer of rights
2006-04-04	B25B	Requested transfer of rights rejected	Owner name: JENAPHARM GMBH AND CO. KG (DE) Free format text: INDEFERIDO O PEDIDO DE TRANSFERENCIA REQUERIDA ATRAVES DA PETICAO NO 019456/SP DE 16/10/2003, POR FALTA DE CUMPRIMENTO DA EXIGENCIA PUBLICADA NA RPI 1807 DE 23/08/2005.
2006-12-26	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]	Free format text: REFERENTE A 9A E 10A ANUIDADES.
2011-12-06	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1877 DE 26/12/2006.